Alcon to Acquire STAAR Surgical in $1.5 Billion Deal to Expand Refractive Surgery Portfolio In a significant move to enhance its surgical vision correction offerings, Alcon a global leader in eye care, has announced its intention to acquire STAAR Surgical…
American Cancer Society and Guardant Health Forge Strategic Partnership to Expand Cancer Screening and Tackle Health Disparities Nationwide The American Cancer Society has announced a strategic partnership with Guardant Health , a leading precision oncology company, to improve access to…
Dallah Healthcare Reports Record-Setting Q2 Revenue Surpassing SAR 1 Billion, Driven by Strategic Acquisitions and Operational Growth; H1 Net Profit Climbs 21% Dallah Healthcare, a leading integrated healthcare provider in Saudi Arabia, has announced its financial results for the second…
Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last patient, last visit in its ongoing Phase 2 clinical trial (NCT05561751) evaluating the safety and efficacy of GPC-100 (burixafor) in…
Turiya Anesthesia, a leading provider of high-quality anesthesia services in Southern California, is thrilled to announce the expansion of its partnership with Emanate Health to now include Foothill Presbyterian Hospital located at 250 South Grand Ave, Glendora, California. Building on…
Global Oral Cancer Rapid Test Kits Market to Reach $1.2 Billion by 2030, Driven by Technological Innovation and Early Diagnosis Demand ResearchAndMarkets.com has released the “Oral Cancer Rapid Test Kits – Global Strategic Business Report,” providing detailed insights into a…
Broc Shot Becomes the First Supplement to Receive the Seal of Recognition From the National Psoriasis Foundation Broc Shot is the first supplement to earn the Seal of Recognition from the National Psoriasis Foundation (NPF). This recognition highlights Broc Shot’s support for skin health from…
Spine BioPharma, Inc. announced today the Phase 3 MODEL trial (MOderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine) evaluating SB-01, a TGF-β antagonist for intradiscal treatment of patients with Chronic Low Back Pain (CLBP) associated with Degenerative Disc Disease (DDD), did…
Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leading provider of technology-enabled payment integrity, eligibility, and related analytics services, announced today its entry into a definitive agreement to be acquired by Machinify, a healthcare intelligence leader and portfolio…
The “Behcet’s Disease Market – A Global and Regional Analysis: Focus on Distribution Channel, Route of Administration, Type, Country, and Region – Analysis and Forecast, 2025-2035″ report has been added to ResearchAndMarkets.com’s offering. The global Behcet’s disease market is highly competitive, characterized by the…
Natera to Present 16 New Transplant Studies at 2025 World Transplant Congress Natera, a global leader in cell-free DNA and precision medicine, announced it will present 16 new research datasets at the 2025 World Transplant Congress (WTC), taking place August…
United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced that it will enter today into two Accelerated Share Repurchase (ASR) agreements with Citibank, N.A. (Citi) to repurchase an aggregate $1 billion of UTHR common stock. United Therapeutics will repurchase these…